Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia ; volume:9 ; number:1 ; day:02 ; month:9 ; year:2009 ; pages:1-9 ; date:12.2009
BMC psychiatry ; 9, Heft 1 (02.9.2009), 1-9, 12.2009
- Urheber
-
Faries, Douglas E.
- Beteiligte Personen und Organisationen
-
Ascher-Svanum, Haya
Nyhuis, Allen W.
Kinon, Bruce J.
SpringerLink (Online service)
- DOI
-
10.1186/1471-244X-9-54
- URN
-
urn:nbn:de:1111-2016030428952
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Faries, Douglas E.
- Ascher-Svanum, Haya
- Nyhuis, Allen W.
- Kinon, Bruce J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Commentary on strategies for switching antipsychotics
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Characteristics of patients with schizophrenia switching from oral antipsychotics to once-monthly paliperidone palmitate (PP1M): a systematic review
Predictors of antipsychotics switching among ambulatory patients with schizophrenia in Ethiopia: a multicenter hospital-based cross-sectional study
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Can Antipsychotics Improve Social Cognition in Patients with Schizophrenia?
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia
Clinical experiences of guided tapering of antipsychotics for patients with schizophrenia– a case series
Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
Commentary on strategies for switching antipsychotics
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Characteristics of patients with schizophrenia switching from oral antipsychotics to once-monthly paliperidone palmitate (PP1M): a systematic review
Predictors of antipsychotics switching among ambulatory patients with schizophrenia in Ethiopia: a multicenter hospital-based cross-sectional study
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Can Antipsychotics Improve Social Cognition in Patients with Schizophrenia?
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia
Clinical experiences of guided tapering of antipsychotics for patients with schizophrenia– a case series
Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
Commentary on strategies for switching antipsychotics
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Characteristics of patients with schizophrenia switching from oral antipsychotics to once-monthly paliperidone palmitate (PP1M): a systematic review
Predictors of antipsychotics switching among ambulatory patients with schizophrenia in Ethiopia: a multicenter hospital-based cross-sectional study
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Can Antipsychotics Improve Social Cognition in Patients with Schizophrenia?
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia
Clinical experiences of guided tapering of antipsychotics for patients with schizophrenia– a case series